Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the execution of premier clinical education programs in the United States and Japan. These strategic engagements reinforce Baird Medical’s market leadership and accelerate its global expansion by establishing standardized clinical excellence for interventional thyroidology.
In New York, the Company successfully facilitated an advanced training initiative at the Columbia University Irving Medical Center, led by Dr. Jennifer Kuo, Director of the Interventional Endocrinology Program and Fellowship Director at Columbia University. This high-level collaboration empowered distinguished specialists Dr. Todd Frieze and Dr. Alberto Monreal from Duke Health, to refine techniques in minimally invasive therapies, including Baird Medical´s Microwave Ablation System for the treatment of Benign Thyroid Tumors. By leveraging Dr. Kuo’s expertise, Baird Medical empowers top-tier institutions to adopt and standardize advanced ablation procedures, expanding patient access to non-surgical options.
Simultaneously, Baird Medical solidified its presence in Asia through a high-profile workshop at Showa Medical University in Yokohama. Opening with remarks from Professor Nobuhiro Fukunari and featuring insights from Professor Ming-An Yu of the China-Japan Friendship Hospital, the event fostered critical academic exchange. This initiative underscores the Company’s commitment to driving the adoption of thyroid ablation across international markets through peer-to-peer education.
